Tracheostomy - Nursing Case Study

Pathophysiology

• Primary mechanism: A tracheostomy provides an alternative airway by creating a direct opening through the neck into the trachea. This bypasses upper airway obstructions and facilitates ventilation in cases of prolonged intubation or conditions like laryngeal injuries.

• Secondary mechanism: It allows for more effective removal of secretions, reducing the risk of infection and improving respiratory efficiency. This is crucial in patients with compromised cough reflexes or neuromuscular disorders.

• Key complication: Stomal infection or tracheal stenosis can occur, leading to potential airway compromise. Regular cleaning and monitoring are vital to mitigate these risks and ensure optimal patient outcomes.

Patient Profile

Demographics:

45-year-old female, school teacher

History:

• Key past medical history: Chronic obstructive pulmonary disease (COPD), hypertension

• Current medications: Lisinopril 10 mg daily, Albuterol inhaler as needed, Fluticasone/Salmeterol 250/50 mcg twice daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Difficulty breathing and increased secretions around tracheostomy site

• Key symptoms: Shortness of breath, cough with thick mucus, fatigue, mild fever

• Vital signs: Temperature 100.4°F (38°C), heart rate 110 bpm, respiratory rate 24 breaths per minute, blood pressure 145/90 mmHg, oxygen saturation 88% on room air

Section 1

As the healthcare team conducts an initial assessment of the patient, they observe several key findings that raise concerns about her current status. The tracheostomy site appears erythematous and swollen with purulent discharge, suggesting a possible stomal infection. Auscultation of the lungs reveals coarse crackles bilaterally, indicating the presence of excess secretions and possible atelectasis. The patient demonstrates increased work of breathing, using accessory muscles, and her oxygen saturation remains low at 88% despite being on room air. The nursing staff note that the patient is experiencing increased fatigue and difficulty clearing her secretions with cough alone.

In response to these assessment findings, blood tests and a sputum culture are ordered to identify any underlying infection. Results reveal a white blood cell count of 14,000/mm³, indicating leukocytosis, and the sputum culture grows Pseudomonas aeruginosa, a common pathogen associated with respiratory infections in patients with COPD and compromised airways. These findings suggest that the patient is likely experiencing a tracheal infection, which is contributing to her respiratory distress and increased secretions.

Given the identified infection and the patient's deteriorating respiratory status, the clinical team initiates a targeted antibiotic therapy, taking into account her allergy to penicillin. In addition, they provide supplemental oxygen to maintain her oxygen saturation above 92% and implement an aggressive chest physiotherapy regimen to aid in secretion clearance. The healthcare team continues to monitor the patient closely for any further changes in her condition, particularly signs of tracheal stenosis or progression of the infection, while also educating her on the importance of regular tracheostomy care to prevent future complications.

Section 2

As the healthcare team continues to closely monitor the patient, they observe a change in her status that requires immediate intervention. Within 48 hours of initiating the targeted antibiotic therapy, the patient's respiratory condition begins to show mixed responses. Although her oxygen saturation improves to 91% with supplemental oxygen at 2 L/min via nasal cannula, her respiratory rate remains elevated at 28 breaths per minute, and she continues to exhibit significant use of accessory muscles. Despite aggressive chest physiotherapy, the patient's ability to clear secretions remains compromised, and she reports an increase in fatigue and difficulty completing daily activities.

During routine tracheostomy site care, the nursing staff note that the erythema and swelling around the stoma have marginally improved, yet the purulent discharge persists, albeit to a lesser degree. A repeat chest auscultation reveals persistent coarse crackles with the addition of wheezing in the upper lobes, suggesting partial airway obstruction and possible bronchospasm. Blood pressure is stable at 118/76 mmHg, but her heart rate has increased to 112 beats per minute, likely a compensatory response to her ongoing respiratory distress.

Recognizing that the patient’s clinical picture might be evolving, the healthcare team orders a repeat chest X-ray and additional blood tests to assess for any progression of infection or emergence of new complications. The X-ray reveals areas of consolidation in the right middle lobe, raising concerns for possible pneumonia development. Concurrently, the laboratory results indicate a slight increase in C-reactive protein levels, suggesting persistent inflammation. These findings prompt the clinical team to re-evaluate the current treatment plan, considering the addition of bronchodilators and possible adjustments to her antibiotic regimen to address the evolving respiratory complications. As they deliberate on the best course of action, the importance of vigilant monitoring and timely intervention remains paramount to prevent further deterioration in the patient's respiratory status.

Section 3

Response to Interventions:

In response to the evolving clinical picture, the healthcare team initiates bronchodilator therapy to address the possible bronchospasm and enhance airway patency. A nebulizer treatment with albuterol is administered, and the patient is closely monitored for changes in respiratory status. Within minutes of the intervention, the patient's wheezing begins to diminish, and her accessory muscle use shows signs of decreasing. Encouragingly, her respiratory rate reduces slightly to 24 breaths per minute, though she still reports fatigue and exertion with minimal activity. Her oxygen saturation remains stable at 91% on 2 L/min of supplemental oxygen, but the team remains vigilant for any further fluctuations in her status.

To address the persistent infection and inflammation indicated by the elevated C-reactive protein and new chest X-ray findings, the decision is made to adjust the antibiotic regimen. The healthcare team consults with the infectious disease specialist, leading to the addition of an antibiotic with broader coverage. Concurrently, chest physiotherapy is intensified, and hydration is optimized to help mobilize respiratory secretions more effectively. Over the next 24 hours, there is a gradual reduction in purulent discharge from the tracheostomy site, and the erythema around the stoma continues to improve.

Despite these positive responses, the team remains cautious, considering the potential for further complications such as pneumonia or worsening bronchospasm. Continuous monitoring of the patient's vital signs, respiratory status, and laboratory markers is prioritized to swiftly identify any adverse developments. As the patient continues to stabilize, discussions also shift towards potential discharge planning and the need for continued respiratory support and follow-up care to prevent recurrence of complications.

Section 4

As the team continues to monitor the patient, new complications begin to emerge. Overnight, the patient's respiratory status shows signs of subtle deterioration. Her respiratory rate increases to 28 breaths per minute, and she begins to exhibit increased use of accessory muscles once again. Despite the supplemental oxygen, her oxygen saturation drops to 88%, prompting immediate reassessment by the healthcare team. Notably, the patient is now exhibiting increased cough and production of thick, tenacious sputum, which is difficult for her to expectorate.

In addition to these respiratory changes, a new set of lab results reveals a marked increase in white blood cell count to 16,000/mm³, suggesting a possible exacerbation of infection. Furthermore, a repeat chest X-ray shows areas of consolidation in the lower lobes, raising suspicion for pneumonia development. The team recognizes the need for prompt intervention to address these findings.

In response, the antibiotic therapy is further tailored, guided by sputum culture results that identify a resistant strain of bacteria. The team also revisits the bronchodilator regimen, considering the addition of a long-acting agent to the treatment plan. Enhanced chest physiotherapy and aggressive pulmonary hygiene are prioritized to facilitate sputum clearance. The patient is closely monitored for any signs of respiratory distress, and discussions around potential escalation of care, including the use of non-invasive ventilation, are initiated to prevent further decline. This strategic approach aims to stabilize the patient's condition and guide her towards recovery while maintaining a vigilant stance against any additional complications that may arise.

Section 5

As the healthcare team implements the revised treatment plan, they closely monitor the patient's response to the interventions. Over the next 24 hours, there is a noticeable shift in the patient's respiratory status. Her respiratory rate remains elevated at 26 breaths per minute, but the use of accessory muscles appears to have diminished slightly, indicating a mild improvement in her breathing effort. However, her oxygen saturation continues to fluctuate between 88% and 90%, despite the administration of high-flow supplemental oxygen.

The sputum culture reveals the presence of a multidrug-resistant Pseudomonas aeruginosa. Consequently, the antibiotic regimen is adjusted to include a combination therapy that targets this specific pathogen. The patient begins receiving inhaled tobramycin alongside intravenous ceftazidime, in accordance with the susceptibility profile. Despite these changes, the patient's cough persists, and she continues to produce large volumes of thick, tenacious sputum. To address this, the respiratory therapy team intensifies chest physiotherapy sessions, employing postural drainage techniques and mechanical insufflation-exsufflation to enhance mucus clearance.

Despite these focused efforts, the patient's white blood cell count remains elevated, now at 17,200/mm³, and she begins to exhibit low-grade fevers, with temperatures reaching 38.3°C (100.9°F). These findings suggest a persistent inflammatory response, possibly indicative of an ongoing infectious process or the body's reaction to the resistant strain. The team decides to initiate a discussion about the feasibility of non-invasive ventilation, considering her fluctuating oxygen levels and the potential for respiratory muscle fatigue. This proactive approach aims to prevent further respiratory decline while allowing the antibiotics and pulmonary interventions time to take effect. As the team continues to evaluate her status, they remain vigilant for any additional complications that may arise, prepared to adjust the treatment plan as necessary to support the patient's recovery.